HPV Testing for Primary Cervical Cancer Screening: A Health Technology Assessment [Internet]

Review
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Mar.

Excerpt

The objective of this health technology assessment (HTA) is to address the policy question by assessing the diagnostic test accuracy, clinical utility, safety, cost-effectiveness, patients’ experiences and perspectives, ethical issues, and implementation issues of HPV testing as a primary screening tool for cervical cancer screening. This HTA was conducted to inform decision-making, policy development, capacity planning, and recommendations around primary HPV-based testing for cervical cancer screening.

Sections

Publication types

  • Review

Grants and funding

Funding: CADTH receives funding from Canada’s federal, provincial, and territorial governments, with the exception of Quebec.